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Paracoccidioides brasiliensis and Paracoccidioides lutzii are dimorphic fungi and are
the etiological agents of paracoccidioidomycosis (PCM). Adhesion is one of the most
important steps in infections with Paracoccidioides and is responsible for the differences
in the virulence of isolates of these fungi. Because of the importance of adhesion to
the establishment of an infection, this study focused on the preliminary development
of a new therapeutic strategy to inhibit adhesion by Paracoccidioides, thus inhibiting
infection and preventing the disease. We used two phage display libraries to select
peptides that strongly bind to the Paracoccidioides cell wall to inhibit adhesion to host
cells and extracellular matrix (ECM) components (laminin, fibronectin, and type I and type
IV collagen). This approach allowed us to identify four peptides that inhibited up to 64%
of the adhesion of Paracoccidioides to pneumocytes in vitro and inhibited the adhesion
to the ECM components by up to 57%. Encouraged by these results, we evaluated the
ability of these peptides to protect Galleria mellonella from Paracoccidioides infection
by treating G. mellonella larvae with the different peptides prior to infection with
Paracoccidioides and observing larval survival. The results show that all of the peptides
tested increased the survival of the larvae infected with P. brasiliensis by up to 64%
and by up to 60% in those infected with P. lutzii. These data may open new horizons for
therapeutic strategies to prevent PCM, and anti-adhesion therapy could be an important
strategy.
Keywords: adhesion, anti-adhesive peptides, phage display, Paracoccidioides spp., paracoccidioidomycosis
INTRODUCTION
Paracoccidioidomycosis (PCM) is a systemic mycosis caused by the dimorphic fungi
Paracoccidioides brasiliensis and Paracoccidioides lutzii that occurs in Latin America and in Brazil,
which is the country with the largest number of endemic areas for this disease in the world. The
incidence of the disease in endemic areas has been estimated to be approximately one to three
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clinical cases per 100,000 inhabitants per year (Coutinho et al.,
2002), and it is an important public health issue.
An infection with Paracoccidioides spp. begins with the
adhesion of fungal cells to host cells, which is mediated by
a special class of proteins present on the cell wall known as
adhesins (Silva, 2008). The pathogen’s ability to colonize and
invade the host tissue is strictly dependent on these proteins and
the adhesion capacity of the fungus. de Oliveira et al. (2015),
using in vivo animal models, demonstrated that the ability to
express adhesins and adhere to the host are decisive factors in
the virulence of different Paracoccidioides spp. isolates.
The inhibition or blocking of fungal adhesion to host cells
may be an innovative and efficient way to prevent infection.
Such strategies would reduce fungal colonization of different host
tissues and nutrient acquisition and, consequently, facilitate the
actions of the host immune system to fight the infection. This
type of therapy is known as anti-adhesion therapy and can be
an effective way to improve the efficacy of PCM treatments.
In support of this idea, de Oliveira et al. (2015) demonstrated
that when blocking two important Paracoccidioides spp. adhesins,
enolase and 14-3-3, using specifics antibodies, host organisms
were able to resist fungal infection and showed increased survival.
Anti-adhesive compounds can competitively inhibit adhesion
by mimicking either microbes or host cell ligands. Alternatively,
antibodies that recognize the surface epitopes on the pathogen
can be used to block adhesion and, in the process, can actively or
passively immunize the host (Krachler and Orth, 2013).
Resistance to anti-adhesive agents may also be expected to
emerge. Resistance to drugs arises spontaneously in a population
through mutations. The persistent use of antibiotics will result
in the death of all non-resistant bacteria. Therefore, only those
with mutations conferring resistance can propagate, resulting
in the quick spread of resistance in a population. However,
unlike with the use of antibiotics, which kill or stop the growth
of susceptible microorganisms, during anti-adhesion therapy,
nonresistant strains can continue to propagate and be transmitted
to new hosts. Any wild-type strains would continue to compete
with resistant strains in untreated individuals. This would
potentially allow sensitive and resistant organisms to propagate
and be transmitted at equivalent rates, dramatically slowing the
emergence of a predominantly resistant population (Ofek et al.,
2003; Cozens and Read, 2012).
Phage display has been extremely important for identifying
and characterizing new high-affinity ligands and their receptors
in the context of specific diseases. It has also been helpful for
the identification of molecules with different applications, from
diagnostic biomarkers to potential targets for use in the treatment
of different infections (Lionakis et al., 2005; Antonara et al., 2007;
Mullen et al., 2007; Shkoporov et al., 2008; Posadas et al., 2012),
since the selected peptides frequently have biological activity
related to the nature of the molecule or cell in a study.
These characteristics of phage display allow for the
identification of therapeutic targets relevant to many biological
processes in an organism and simultaneously allow for the
isolation and characterization of peptide antagonists or agonists
for specific targets. Therefore, peptides isolated via phage display
can be exploited for the development of novel therapeutic agents
for use in rational drug design, targeted therapy, gene therapy,
vaccine production, diagnostic testing, and other applications
(Sergeeva et al., 2006; Giordano et al., 2009).
This study proposed the use of the phage display technique
to select peptides that interacted with molecules and receptors
involved in the interaction of Paracoccidioides spp. with host
and in that way, evaluated these selected peptides as candidates
for anti-adhesive molecules to be a new alternative therapy
against PCM.
MATERIALS AND METHODS
Paracoccidioides Isolates
Two Paracoccidioides isolates were used: Pb18 (P. brasiliensis)
and Pl01 (P. lutzii), maintained in vitro in Fava Netto’s medium
at 37◦C (Fava Netto, 1961). The handle of Paracoccidioides
spp. cultures was made in a Class II Biological Safety
Cabinet according recommendations of American Type Culture
Collection (ATCC) and Brazilian Ministry of Health, Secretariat
of Science, Technology and Strategic Inputs (Ministério da Saúde
and Estratégicos, 2006).
Phage Display Peptides Libraries X6 and
CX8C
Phage libraries were produced using the vector fUSE55 and
the methodology developed by George Smith (Smith and Scott,
1993), with modifications to improve the efficiency and the
number of final clones (Koivunen et al., 1993; Koivunen
et al., 1999). The libraries were produced and provided by
Dr. Ricardo José Giordano from the Laboratory of Vascular
Biology, University of Sao Paulo (USP) and were X6 (a linear
library) and CX8C (a cyclic library; X represents any amino
acid, and C = cysteine that allows for cyclical peptides) libraries
(Michaloski et al., Submitted).
Selection of Peptides That Bind to
P. brasiliensis
The BRASIL (Biopanning and Rapid Analysis of Selective
Interactive Ligands) technique (Giordano et al., 2001) was used
for the selection of peptides that bind to Paracoccidioides spp.
This technique consists of the selection of phages that bind
to live cells and the use of a two-phase system to separate
the cells and phages in a single centrifugation step. First, 109
transduction units (TU) of each phage display library were
separately incubated with Saccharomyces cerevisiae (S288C) (106
cells) in 100 µl of PBS. After 3 h on ice, the suspensions
containing the phages and the cells were transferred to the top of
a nonmiscible organic lower phase known as BRASIL oil [dibutyl
phthalate:cyclohexene (9:1) v/v] and centrifuged (10,000 × g,
10 min, 25◦C). After centrifugation, the supernatants containing
phages that did not bind to S. cerevisiae were recovered and
transferred to a suspension of 106 Pb18 cells. After 3 h on
ice, the cell suspensions were again transferred on to BRASIL
oil and centrifuged at 10,000 × g for 10 min. The pellets of
Pb18 cells that formed at the bottom of the organic phase were
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collected, and the phages bound to the cells were recovered via
infection with log-phase E. coli K91 in LB medium supplemented
with kanamycin and tetracycline (100 µg/mL and 20 µg/mL,
respectively) and incubated at 37◦C, with rotation at 250 rpm,
for 20 h. The amplified phages were recovered from the culture
medium via precipitation with polyethylene-glycol/NaCl and
were used for subsequent rounds of selection (second and third)
to further enrich for phages from each library that bound to Pb18
cells.
Binding Assays
Paracoccidioides brasiliensis, P. lutzii, and S. cerevisiae cells were
incubated with 109 TU of the phage to be tested, as described
above. After 2 h of incubation on ice, they were transferred to
the top of BRASIL oil as previously described in the item 2.4 and
centrifuged (10,000 × g, 10 min, 25◦C). The pellet was placed
in a new tube, and the phages were recovered via infection with
E. coli K91. Serial dilutions were seeded onto LB/Kan/Tet plates
to quantify the number of phage bound to each receiver. As a
control P. brasiliensis and P. lutzii cells were incubated with 109 of
the insertless phage Fd-tet. Three independent experiments were
performed.
Inhibition of Paracoccidioides spp.
Adhesion to Extracellular Matrix (ECM)
Components by the Selected Peptides
Using Enzyme Linked Immunosorbent
Assay (ELISA)
Ninety-six-well plates were separately pre-coated with 10 µg/mL
of each tested ECM component (laminin, fibronectin, and type
I and type IV collagen) in a 0.05 M carbonate buffer (pH 9.6)
at room temperature for 1 h. The plates were then washed
with PBS/Tween-20, 0.05% (PBS-T) and blocked with 1% bovine
serum albumin (BSA) for 2 h at 37◦C. The two Paracoccidioides
isolates (Pb18 and Pl01, 106 cells/mL) were incubated with
200 µg/mL of each studied peptide, which were synthesized by
the Chinese Peptide Company (China), at 37◦C, with rotation at
250 rpm, for 1 h. These inocula were incubated with the ECM
components for 15 h at 37◦C. The plates were washed with PBS-
T, and an anti-cell free Paracoccidioides antibody (1:100 in PBS-T
and 0.5% BSA) (Blotta and Camargo, 1993) was added for 1 h
at 37◦C. Another wash cycle was performed, and a secondary
antibody, anti-rabbit IgG-HRP (1:2000 in PBS-T and 0.5% BSA),
was added for 1 h at 37◦C. The colorimetric reaction was
observed by adding a solution of 0.2 M sodium phosphate, 0.1 M
citric acid, 0.4 mg/mL o-phenylenediamine, and 30% hydrogen
peroxide for 10 min, followed by the addition of 3 M hydrochloric
acid. Absorbance was measured at 490 nm and converted to
percent inhibition. For this conversion, Paracoccidioides spp. cells
without treatment were used as a control, and the absorbance
of this control was set as 100% adhesion. The difference in
the absorbance in the treated Paracoccidioides spp. cells relative
to absorbance in the control was considered the percentage of
adhesion inhibition. This experiment was performed in triplicate,
with three independent experiments.
Inhibition of Paracoccidioides spp.
Adhesion to A549 Pneumocytes Cell Line
by the Selected Peptides Using ELISA
The continuous culture of A549 cells line took place in F-12
Nutrient Mixture (HAM-F12) medium supplemented with 10%
fetal bovine serum (FBS) in sterile plastic bottles maintained
at 36.5◦C with 5% CO2. After 3–4 days, the bottles were
trypsinized by washing the cell monolayer with 1 mL of a 0.2%
trypsin ATV solution (Adolfo Lutz) supplemented with 0.02%
EDTA. After 1–2 min, the cells were homogenized with variable
volumes of HAM-F12 medium supplemented with 10% of FBS
to neutralize the trypsin. The total volume of the cell suspension
was determined to achieve a concentration of 106 cells/mL. For
the assay, 105 A549 pneumocytes were added to each well of
a 96-well plate and then infected over 15 h (37◦C with 5%
CO2) with the different Paracoccidioides isolates (Pb18 and Pl01,
106 cells/mL) that were previously incubated with 200 µg/mL
of each studied peptide at 37◦C for 1 h, with rotation at
250 rpm. After incubation, ELISAs were performed as described
in the Section “Inhibition of Paracoccidioides spp. Adhesion
to Extracellular Matrix (ECM) Components by the Selected
Peptides Using Enzyme Linked Immunosorbent Assay (ELISA).”
In this experiment, untreated Paracoccidioides spp. cells were also
used as controls. This experiment was performed in triplicate,
with three independent experiments.
Determination of the Antifungal Activity
of the Peptides
The minimum inhibitory concentration (MIC) of each peptide
was determined following the standardized method in the M27-
A3 document CLSI (2008). Amphotericin B (Sigma) was used
as a control, and the final concentrations of peptides used
ranged from 400 to 0.008 µg/mL after the addition of the
inocula. Both peptides and amphotericin B were prepared with
RPMI 1640 medium (Gibco) supplemented with 2% glucose
(RPMI 1640-2%). The fungal cells were suspended in PBS, and
the number of viable cells was estimated by staining them
with Trypan blue and counting them with a haemocytometer.
A suspension with 106 cells/mL was diluted at 1:50 in PBS,
and then was diluted at 1:20 in RPMI 1640-2% Glc. The plates
were incubated at 35◦C, with rotation at 150 rpm, for 48 h,
and the MABA (Microplate AlamarBlue Assay) was employed.
Samples were incubated for an additional 24 h, for a total of
72 h for the final determination of MIC values, according de
Paula e Silva et al. (2013). Three independent experiments were
performed.
Determination of the Cytotoxicity of the
Peptides Using the MTT
(3-(4,5-Dimethylthiazol-2-yl)-2,5-
Diphenyltetrazolium Bromide) Cell
Viability Test
The cytotoxicity of the selected peptides was determined using
the A549 pneumocyte linage. The peptides were evaluated at
concentrations ranging from 400 to 25 µg/mL using the MTT
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cell viability test according Denizot and Lang (1986) and Ferrari
et al. (1990). For this, plates were prepared with 106 cells/well
in HAM-F12 medium. Before the experiments, the medium was
removed, and 100 µL of each tested dilution of the peptides
in HAM-F12 was placed in contact with the cells. The plates
were incubated at 37◦C under 5% CO2 in the dark for 24 h.
The solutions were then removed, 10 µL of MTT solution
(5 mg/L) was added, and the plates were incubated again at
37◦C for 4 h. After incubation, the MTT solution was removed,
100 µl of isopropanol was added to dissolve the precipitate,
and the plates were read spectrophotometrically at 595 nm
DO. The dead control was 10% hydrogen peroxide. The live
control was untreated cells, and the reading from this control
was considered as 100% living cells. This experiment was
performed in triplicate, with three independent experiments, and
the percentage of viable cells was calculated using the following
formula:
% Viable cells = mean of the test× 100/mean of the negative control.
In vivo Toxicity of the Peptides in Galleria
mellonella
The toxicity of the peptides was evaluated using 2, 4, 8, 50, 100,
200, and 400 µg/larva of each peptide. For this assay, groups of
16 larvae were treated with the various concentrations tested and
incubated at 37◦C. The survival of the larvae was evaluated every
day for 7 days after treatment. As controls, we used a group of
larvae treated with PBS and a group of untreated larvae. Three
independent experiments were performed.
Capacity of Peptides to Prevent the
Infection of G. mellonella with
Paracoccidioides spp.
Larval groups (n= 16) were separately treated with 100µg/larvae
of each peptide for 3 h. The larvae were subsequently infected
with 5 × 106 cells/larva of Paracoccidioides spp. isolates (Pb18 or
Pb01) according to Scorzoni et al. (2015), and larval survival was
then observed daily for 1 week. The peptide treatments and fungal
inoculations were performed with 10 µL Hamilton syringes
(Hamilton, USA). Larval death was evaluated based on the visual
confirmation of a lack of movement after the larvae were touched
with tweezers. As controls, groups of larvae treated with PBS and
infected with Pb18 or Pb01 and a group of uninfected larvae only
treated with PBS were used. Three independent experiments were
performed.
Effect of Peptide Treatment on
Haemocyte Density
Groups of 16 larvae were inoculated with 100 µg/larvae of each
peptide and incubated at 37◦C for 3 h. The peptide inoculations
were performed with 10 µL Hamilton syringes (Hamilton, USA).
After incubation, the haemolymph from each larva was collected
separately and diluted 1:10 in PBS. The cells were counted in a
haemocytometer under a bright field microscope. A group treated
with PBS was used as the control. Three independent experiments
were performed.
Statistical Analysis
Statistical analyses and graph design were performed using
GraphPad Prism version 5.00 (GraphPad Software, San Diego,
CA, USA), and the results were considered significant when
p < 0.05. Binding assay, MTT test and the haemocyte density
test results were analyzed using one-way ANOVAs and Tukey’s
post hoc tests. Survival assays were analyzed using Mantel–Cox
log-rank tests.
RESULTS
Selection of Peptides That Bound to the
Surface of P. brasiliensis Cells via Phage
Display Using BRASIL Technique
We employed the BRASIL technique to select peptides that
bound to P. brasiliensis using linear (X6) and cyclic (CX8C)
peptide libraries of different sizes to increase the variety of
peptides available for study. A pre-clearing step was added to
our selection protocol to favor the selection of peptides that
specifically bound to this species. Phage libraries were first
incubated with the non-pathogenic yeast S. cerevisiae to remove
ubiquitously binding peptides. The remaining unbound phages
were transferred to the pathogenic P. brasiliensis strain, and
bound phages were recovered for further rounds of selection.
After three rounds of selection, we observed an enrichment of
phages bound to P. brasiliensis compared to the second round
(2.3 times for the X6 library and five times for CX8C library),
indicating an increase in phages that could bind to the fungal cells
with a high affinity.
At the end of the selection process, 96 individual phage clones
from each library were randomly picked from the third round
and sequenced, and 84 and 76 sequences were obtained from the
X6 and CX8C libraries, respectively. Four peptides were selected
because they were displayed by multiple phages (Table 1): three
peptides from the X6 library and one from CX8C library. These
peptides were selected for further study because they were likely
to have higher affinities for P. brasiliensis cells.
Binding Assays
We evaluated the binding of each peptide to P. brasiliensis
and P. lutzii and to the non-pathogenic yeast S. cerevisiae.
As a control, we evaluated the binding of the insertless
phage Fd-tet to P. brasiliensis and P. lutzii cells. We observed
TABLE 1 | Peptide sequences and frequency.
Peptides sequences N Percentage (%)
LVGRVV 5 5.9
LDFVVG 5 5.9
CSVSALGGAC 3 3.9
VVAGSV 3 3.5
Selected peptides amino acids sequences. The other sequences obtained from
both libraries demonstrated a frequency of 1.3% or less and because of this were
not selected for further studies.
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that all peptides showed greater binding to P. brasiliensis
(phage LVGRVV, 9.7-fold; phage LDFVVG, 7.5-fold; phage
CSVSALGGAC, 10.5-fold; and phage VVAGSV, 8.1-fold) and
P. lutzii (phage LVGRVV, 9.7-fold; phage LDFVVG, 30.8-fold;
phage CSVSALGGAC, 4.1-fold; and phage VVAGSV, 5.9-fold)
compared with the binding of the Fd-tet control phage (Figure 1).
None of the phages tested were found to significantly bind
to S. cerevisiae, indicating that the pre-clearing step efficiently
removed the peptides that bound to these cells. In summary,
our validation assays confirmed that all selected peptides bound
to specific cell surface ligands of the two species of the genus
Paracoccidioides, P. brasiliensis (isolate Pb18) and P. lutzii (isolate
Pl01).
Inhibition of Paracoccidioides spp.
Adhesion to ECM Components and A549
Pneumocytes by the Selected Peptides
Using an Inhibition Enzyme Linked
Immunosorbent Assay (inh-ELISA)
Assays were conducted using four different ECM components
(laminin, fibronectin, and collagen types I and IV) (Figure 2)
and the A549 pneumocyte line (Figure 3). The results indicate
the strong potential of the peptides to inhibit the adhesion of
P. brasiliensis and P. lutzii and indicate that these peptides might
bind to some components of the fungal cell wall important for the
Paracoccidioides-host interaction.
All the peptides tested inhibited the adhesion to all of the
ECM components, with inhibition ranging from 10 to 60%
depending on the strain and the ECM component (Figure 2).
LVGRVV more efficiently inhibited the adhesion of P. brasiliensis
to fibronectin (39%) and the adhesion of P. lutzii to laminin
(57%). LDFVVG efficiently inhibited the adhesion of both fungi
to fibronectin and type I and type IV collagen (from 21 to 34%
inhibition). CSVSALGGAC and VVAGSV efficiently inhibited
the adhesion of both fungi to laminin, with an inhibition rate
ranging from 38 to 51%.
All tested peptides were able to inhibit the adhesion of
P. brasiliensis and P. lutzii to A549 pneumocytes in a similar
manner. The inhibition of the adhesion of the Pb18 and Pl01
strains to A549 pneumocytes ranged from 40 to 60%, respectively,
for all the studied peptides (Figure 3).
Determination of the Antifungal Activities
of the Peptides
The peptides did not kill or inhibit the growth of P. brasiliensis
and P. lutzii at any tested concentration, which ranged from 400
to 0.008 µg/mL (data not shown).
FIGURE 1 | Selected peptides bind to Paracoccidioides cells. Binding assays of the four selected phages to Paracoccidioides brasiliensis (Pb18),
Saccharomyces cerevisiae, and Paracoccidioides lutzii (Pl01) isolates. Binding of LVGRVV (A), LDFVVG (B), CSVSALGGAC (C), and VVAGSV (D) phages. Binding of
the control phage Fd-tet to P. brasiliensis (Pb18) and P. lutzii is indicated. TU, transduction units. ∗p < 0.05 (compared with Fd control); 1p < 0.05 (compared with
the S. cerevisiae control).
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FIGURE 2 | Inhibition of P. brasiliensis and P. lutzii adhesion by the selected peptides to extracellular matrix (ECM) components laminin, fibronectin,
type I and type IV collagen tested via inhibition ELISAs. (A) Inhibition by LVGRVV, (B) inhibition by LDFVVG, (C) inhibition by CSVSALGGAC, and (D) inhibition
by VVAGSV.
Determination of the Cytotoxicity of the
Peptides Using the MTT Cell Viability
Test
The peptides did not show cytotoxicity. The percentage of
viable cells was over 92% for LVGRVV and LDFVVG and was
100% for CSVSALGGAC and VVAGSV at a concentration of
200 µg/mL, which was the concentration used in the inh-ELISA.
All concentrations lower than 100µg/mL showed no cytotoxicity
(data not shown).
Toxicity of Peptides in G. mellonella
No larvae died at any concentration tested, demonstrating
that the peptides are nontoxic to the larvae. These results
complemented the in vitro tests in which the peptides showed no
toxicity to A549 pneumocytes.
Protection of G. mellonella from Infection
with P. brasiliensis and P. lutzii by the
Peptides
All peptides significantly (p < 0.05) protected the larvae against
P. brasiliensis infections (Figure 4). Survival rates of 50%, 31%,
64%, and 37% were observed for larvae treated with the LVGRVV,
LDFVVG, CSVSALGGAC, and VVAGSV peptides, respectively.
The survival time increased when the larvae were treated with
each of the peptides. Untreated larvae began to die after 1 day, but
the treated larvae began to die after 3 days for LVGRVV, 4 days for
LDFVVG and CSVSALGGAC and 2 days for VVAGSV, and in all
cases, 7 days was not sufficient to kill all treated larvae, whereas
7 days were sufficient to kill all untreated larvae.
Figure 5 shows the results obtained for peptide-treated larvae
infected with P. lutzii. Only the VVAGSV peptide was able
to significantly (p < 0.05) protect the larvae against P. lutzii
infections, resulting in a survival rate of 60% at the end
of the seventh day of infection. However, the LVGRVV and
CSVSALGGAC peptides were able to significantly (p < 0.05)
increase the survival time. Treatment with LDFVVG did not
affect larval survival after P. lutzii infection. The survival time
increased when the larvae were treated with each peptide.
Untreated larvae began to die after 4 days, whereas larvae treated
with the different peptides began to die after 5 days. After
treatment with the VVAGSV peptide, 7 days were not sufficient
to kill all of the larvae (Figure 5).
Determination of Haemocyte Density
after Treatment with the Selected
Peptides
Larvae were treated with the selected peptides for 3 h, and
we observed that peptide VVAGSV stimulated significantly the
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FIGURE 3 | Inhibition of P. brasiliensis and P. lutzii adhesion to A549 cells by the selected peptides tested via inhibition ELISAs. (A) Inhibition by
LVGRVV, (B) inhibition by LDFVVG, (C) inhibition by CSVSALGGAC, and (D) inhibition by VVAGSV.
FIGURE 4 | Capacity of selected peptides to protect G. mellonella larvae against P. brasiliensis infection. The graphs show the percentage of
G. mellonella larvae treated with the selected peptides and challenged with P. brasiliensis. (A) Treatment with LVGRVV, (B) treatment with LDFVVG, (C) treatment
with CSVSALGGAC, and (D) treatment with VVAGSV. ∗Statistical significance (p < 0.05) is relative to Pb18 (infected and untreated larvae).
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FIGURE 5 | Capacity of the selected peptides to protect G. mellonella larvae against P. lutzii infection. The graphs show the percentage of G. mellonella
larvae treated with the selected peptides and challenged with P. lutzii. (A) Treatment with LVGRVV, (B) treatment with LDFVVG, (C) treatment with CSVSALGGAC,
and (D) treatment with VVAGSV. ∗Statistical significance (p < 0.05) is relative to Pl01 (infected and untreated larvae).
FIGURE 6 | Haemocyte density. The graph shows alterations in haemocyte density in the different G. mellonella larvae groups after 3 h of treatment with LVGRVV,
LDFVVG, CSVSALGGC, and VVAGSV peptides. ∗p < 0.05.
haemocyte production (p < 0.05) compared with production in
the PBS control (Figure 6).
DISCUSSION
Paracoccidioides spp. express various adhesins, and the adhesion
mediated by these molecules is the most important step
in a successful infection. Therefore, inhibiting adhesion to
host cells may be an interesting way to protect the host
from Paracoccidioides infections. The use of molecules that
interfere with the adhesion of pathogens, known as anti-
adhesion therapy, appears to be an efficient way to prevent
infection because if the fungus cannot adhere, it is incapable
of colonizing the host tissue, and its acquisition of nutrients
is impeded, which facilitates resistance by the host’s immune
system.
In this study, four peptides selected by phage display promoted
the in vitro inhibition (up to 57%) of P. brasiliensis and
P. lutzii adhesion to different ECM components and to A549
pneumocytes (up to 64%). These results indicate that the anti-
adhesive properties of these peptides could prevent the adhesion
of Paracoccidioides spp. We demonstrated that these peptides did
not have antifungal activity, which means that the reduction in
the adhesion of both fungi was not caused by a loss of fungal
viability during the experiments. In addition, the cytotoxicity of
these peptides was tested using the MTT test, and no cytotoxicity
was observed in A549 pneumocytes or in vivo in G. mellonella.
These results indicate the possible safe therapeutic use of these
substances.
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We preliminarily tested the efficiency of these peptides
to protect the host against Paracoccidioides infections in
G. mellonella, an alternative animal model for pathogenicity and
virulence studies on fungal pathogens (Brennan et al., 2002; Slater
et al., 2011) that has recently been used to study the pathogenicity
and virulence of Paracoccidioides spp. (de Oliveira et al., 2015;
Marcos et al., 2015; Scorzoni et al., 2015).
The treatment of G. mellonella prior to P. brasiliensis infection
demonstrated that the peptides were able to prevent larval death
for up to 7 days after infection, with survival rates of 50%
(LVGRVV), 31% (LDFVVG), 64% (CSVSALGGAC), and 37%
(VVAGSV), and treatments increased the survival time of the
larvae. For P. lutzii, only the VVAGSV peptide increased the
survival rate of larvae after infection, to 60%; however, the
LVGRVV and CSVSALGGAC peptides were able to significantly
increase larval survival times. These results revealed that all
peptides have the potential to prevent Paracoccidioides spp.
infection. We also observed that treatment with the peptides
led to an increase in larval survival times when infected with
both fungi. We believe that the peptides bind to molecules on
the fungal cells important for adhesion, obstructing infection
by the fungus. Furthermore, these peptides might compete
with the fungus for binding sites on the host cell, also
inhibiting fungal adhesion and facilitating the ability of the
host to resolve the infection or making the infectious process
difficult for the fungus. These characteristics show us that all
the selected peptides are potential anti-adhesive therapeutic
agents.
The stimulation of the immune response to counter the
undesirable effects caused by the disease and reduce fungal
burden are objectives to be explored for the effective treatment of
severe PCM cases (Travassos and Taborda, 2012). However, since
PCM primarily affects rural workers, the disease is associated
with significant social and economic factors that mostly affect
less aﬄuent populations (Shikanai-Yasuda et al., 2006; de
Amorim et al., 2013), so the development of new molecules
that could work as a vaccine directed at high-risk populations
could be an important step in effective prophylaxis for this
disease.
The body cavity of G. mellonella contains haemolymph,
which has functions similar to those of blood in mammals,
carrying nutrients and signal molecules and participating in
gas exchange (Bergin et al., 2003). Additionally, haemolymph
contains cells known as haemocytes and antimicrobial peptides
that can immobilize and kill invading microbes (Cotter et al.,
2000).
We observed that when larvae were treated with the VVAGS
peptide, haemocyte density increased (p < 0.05). These results
suggest that this peptide can modulate the immune system of
the larvae, increasing haemocyte production. This appeared to
trigger a protective effect in the host, resulting in the protection
of the larvae against Paracoccidioides spp. infections, which is
important in anti-fungal therapy.
A peptide known as p10, derived from the P. brasiliensis
adhesin gp43, has been shown to be recognized by the T
lymphocytes of mice and humans and has a protective effect, and
isogenic mice developed a 200-fold less intense infection when
immunized with this peptide (Taborda et al., 1998). Furthermore,
a combination of p10 immunization with various antifungal
drugs showed an additive protective effect, with a significant
reduction in CFU counts after 60 and 120 days of infection.
Histological analyses revealed little or no P. brasiliensis cells in
mouse tissue, and the use of p10 combined with drugs improved
the standard therapy with antifungal drugs and reduced the
duration of treatment (Marques et al., 2006). This type of
combined therapy was also effective in anergic mice, and anergy
is a common in patients suffering from acute and sub-acute PCM
(Marques et al., 2008). Currently, studies using a DNA vaccine
coding for p10 have shown satisfactory results; the administration
of the vaccine 1 month before or after infection induced a
significant reduction in the fungal burden in the lungs of mice,
indicating that immunization with this vaccine is a powerful tool
for the prevention and treatment of PCM (Rittner et al., 2012).
The selected peptides demonstrated anti-adhesive activity,
inhibiting the adhesion of P. brasiliensis and P. lutzii to
pneumocytes and ECM components. The treatment of infected
G. mellonella with the peptides increased larval survival
and increased haemocyte density, demonstrating a possible
immunomodulatory effect in the larvae that can affect their
survival. More studies are necessary to understand the
mechanisms involved during the use of these peptides, including
studies with murine models and studies focused on the combined
use of the peptides and traditional antifungal therapies. However,
our study shows that these molecules might provide new insights
on the treatment and prevention of PCM.
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